Article Listing - Ceredase Approval in Europe

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

Sales of beta-2 agonists in Europe will grow from $485 million in 1990 to almost $983 million by 1995, or...

TAMOXIFEN OF BENEFIT IN OSTEOPOROSIS?

6 April 1992

A US study looking at the effects of Imperial Chemical Industries' synthetic anti-estrogen Nolvadex (tamoxifen) in post-menopausal women with early-stage...

GERMAN PRICE SUPPORT EXTENDED

6 April 1992

The leading German health insurance funds have announced further fixed-price support arrangements for a new range of drug products, and...

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

ENZON AND CYTOCLONAL PHARMACEUTICS

6 April 1992

Enzon Inc has entered into an agreement with Cytoclonal Pharmaceutics to apply the former's drug delivery technologies to Cytoclonal products...

NEW EDITOR OF D&TB

6 April 1992

Joe Collier, reader and consultant in clinical pharmacology at St George's Hospital Medical School, London, has been appointed editor of...

New Swiss Hospital Costs Program

6 April 1992

The Swiss Federal Council has come out in support of the need for severe measures to combat increasing health care...

WELLCOME SHARE FLOAT "MANAGERS"

6 April 1992

Following the recent announcement of its decision to float a further bank of shares in Wellcome plc, the Wellcome Trust...

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

New sales and earnings records were achieved in 1991 by American Home Products (Mar-ketletter January 20). The year was said...

DEPRESSION: THE COST TO SOCIETY

6 April 1992

The costs of depression to the National Health Service in the UK are L 333 million per year, according to...

Showing 94431-94440 of 95372 articles